288 related articles for article (PubMed ID: 28429289)
1. The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV.
Harrison JD; Dochney JA; Blazekovic S; Leone F; Metzger D; Frank I; Gross R; Hole A; Mounzer K; Siegel S; Schnoll RA; Ashare RL
J Neurovirol; 2017 Aug; 23(4):550-557. PubMed ID: 28429289
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.
Nichols SL; Bethel J; Kapogiannis BG; Li T; Woods SP; Patton ED; Ren W; Thornton SE; Major-Wilson HO; Puga AM; Sleasman JW; Rudy BJ; Wilson CM; Garvie PA;
J Neurovirol; 2016 Apr; 22(2):218-30. PubMed ID: 26463526
[TBL] [Abstract][Full Text] [Related]
3. Association of long-term patterns of depressive symptoms and attention/executive function among older men with and without human immunodeficiency virus.
Armstrong NM; Surkan PJ; Treisman GJ; Sacktor NC; Irwin MR; Teplin LA; Stall R; Martin EM; Becker JT; Munro C; Levine AJ; Jacobson LP; Abraham AG
J Neurovirol; 2017 Aug; 23(4):558-567. PubMed ID: 28429290
[TBL] [Abstract][Full Text] [Related]
4. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
Ma Q; Vaida F; Wong J; Sanders CA; Kao YT; Croteau D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; Morgello S; Simpson DM; Heaton RK; Grant I; Letendre SL;
J Neurovirol; 2016 Apr; 22(2):170-8. PubMed ID: 26407716
[TBL] [Abstract][Full Text] [Related]
5. Empiric neurocognitive performance profile discovery and interpretation in HIV infection.
Gomez D; Power C; Gill MJ; Koenig N; Vega R; Fujiwara E
J Neurovirol; 2019 Feb; 25(1):72-84. PubMed ID: 30519968
[TBL] [Abstract][Full Text] [Related]
6. The association between cigarette smoking, virologic suppression, and CD4+ lymphocyte count in HIV-Infected Russian women.
Brown JL; Winhusen T; DiClemente RJ; Sales JM; Rose ES; Safonova P; Levina O; Belyakov N; Rassokhin VV
AIDS Care; 2017 Sep; 29(9):1102-1106. PubMed ID: 28497980
[TBL] [Abstract][Full Text] [Related]
7. Better quality of life with neuropsychological improvement on HAART.
Parsons TD; Braaten AJ; Hall CD; Robertson KR
Health Qual Life Outcomes; 2006 Feb; 4():11. PubMed ID: 16504114
[TBL] [Abstract][Full Text] [Related]
8. Initiation of antiretroviral therapy after the critical neuronal developmental period of the second postnatal year affects white matter microstructure in adolescents living with HIV.
Hoare J; Heany SJ; Fouche JP; Phillips N; Joska JA; Myer L; Zar HJ; Stein DJ
J Neurovirol; 2019 Apr; 25(2):254-262. PubMed ID: 30617850
[TBL] [Abstract][Full Text] [Related]
9. Subtype associations with HIV-associated neurocognitive disorder in China.
Day TR; Smith DM; Heaton RK; Franklin D; Tilghman MW; Letendre S; Jin H; Wu Z; Shi C; Yu X; Pérez-Santiago J
J Neurovirol; 2016 Apr; 22(2):246-50. PubMed ID: 26306690
[TBL] [Abstract][Full Text] [Related]
10. Chronic Tobacco-Smoking on Psychopathological Symptoms, Impulsivity and Cognitive Deficits in HIV-Infected Individuals.
Chang L; Lim A; Lau E; Alicata D
J Neuroimmune Pharmacol; 2017 Sep; 12(3):389-401. PubMed ID: 28303534
[TBL] [Abstract][Full Text] [Related]
11. Relation of Steatosis to Neurocognitive Function in People Living with HIV.
Marić D; Brkić S; Ignjatović VB; Nikolaševic Ž; Ilić D; Vujanović M; Drvendžija Z; Galić BS
Curr HIV Res; 2020; 18(3):172-180. PubMed ID: 32106801
[TBL] [Abstract][Full Text] [Related]
12. Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV?
Tsima B; Ratcliffe SJ; Schnoll R; Frank I; Kolson DL; Gross R
J Int Assoc Provid AIDS Care; 2018; 17():2325958218768018. PubMed ID: 29667531
[TBL] [Abstract][Full Text] [Related]
13. Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007.
Bénard A; Mercié P; Alioum A; Bonnet F; Lazaro E; Dupon M; Neau D; Dabis F; Chêne G;
PLoS One; 2010 Jan; 5(1):e8896. PubMed ID: 20126646
[TBL] [Abstract][Full Text] [Related]
14. White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration.
Cysique LA; Soares JR; Geng G; Scarpetta M; Moffat K; Green M; Brew BJ; Henry RG; Rae C
J Neurovirol; 2017 Aug; 23(4):539-547. PubMed ID: 28324319
[TBL] [Abstract][Full Text] [Related]
15. Various associations of aging and long-term HIV infection with different neurocognitive functions: detailed analysis of a Japanese nationwide multicenter study.
Komatsu K; Kinai E; Sakamoto M; Taniguchi T; Nakao A; Sakata T; Iizuka A; Koyama T; Ogata T; Inui A; Oka S;
J Neurovirol; 2019 Apr; 25(2):208-220. PubMed ID: 30859496
[TBL] [Abstract][Full Text] [Related]
16. Factors related to HIV-associated neurocognitive impairment differ with age.
Fogel GB; Lamers SL; Levine AJ; Valdes-Sueiras M; McGrath MS; Shapshak P; Singer EJ
J Neurovirol; 2015 Feb; 21(1):56-65. PubMed ID: 25404233
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive impairments in non-deprived smokers--results from a population-based multi-center study on smoking-related behavior.
Wagner M; Schulze-Rauschenbach S; Petrovsky N; Brinkmeyer J; von der Goltz C; Gründer G; Spreckelmeyer KN; Wienker T; Diaz-Lacava A; Mobascher A; Dahmen N; Clepce M; Thuerauf N; Kiefer F; de Millas JW; Gallinat J; Winterer G
Addict Biol; 2013 Jul; 18(4):752-61. PubMed ID: 22339903
[TBL] [Abstract][Full Text] [Related]
18. The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition.
Delle Donne V; Ciccarelli N; Massaroni V; Borghetti A; Dusina A; Farinacci D; Visconti E; Tamburrini E; Fabbiani M; Di Giambenedetto S
J Neurovirol; 2020 Dec; 26(6):899-907. PubMed ID: 32839950
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women.
Cohen RA; Boland R; Paul R; Tashima KT; Schoenbaum EE; Celentano DD; Schuman P; Smith DK; Carpenter CC
AIDS; 2001 Feb; 15(3):341-5. PubMed ID: 11273214
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive impairment and gray matter volume reduction in HIV-infected patients.
Kato T; Yoshihara Y; Watanabe D; Fukumoto M; Wada K; Nakakura T; Kuriyama K; Shirasaka T; Murai T
J Neurovirol; 2020 Aug; 26(4):590-601. PubMed ID: 32572834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
